Phosphoinositide 3-kinase inhibitor

systematic review meta-analysis network meta-analysis

Select advanced breast cancer (metastatic) All type of patientHR+ HER2 -       selective PI3K inhibitor alpelisibtaselisib vs endocrine therapy alone      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result
advanced breast cancer (metastatic)
taselisib
SANDPIPER, 2018    NCT	taselisib + fulvestrant	fulvestrant alone	2L ER PIK3CA-MUT		Low risk of bias	-